Trial Outcomes & Findings for Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025 (NCT NCT04079816)
NCT ID: NCT04079816
Last Updated: 2022-10-19
Results Overview
ORi is an index value without a unit and ORi does not directly measure PaO2. Therefore, sensitivity, specificity, and concordance are calculated to evaluate changes in ORi relative to the changes in PaO2.
COMPLETED
29 participants
1-5 hours per subject
2022-10-19
Participant Flow
Of of the 54 enrolled participants, 29 met inclusion criteria and proceeded to the study. The remainder of the enrolled participants include screen failures and subjects that did not proceed due to time constraints.
Participant milestones
| Measure |
INVSENSOR00025
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive INVSENSOR00025 sensor.
INVSENSOR00025: Noninvasive pulse oximeter sensor
|
|---|---|
|
Overall Study
STARTED
|
29
|
|
Overall Study
COMPLETED
|
26
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
INVSENSOR00025
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive INVSENSOR00025 sensor.
INVSENSOR00025: Noninvasive pulse oximeter sensor
|
|---|---|
|
Overall Study
Request of Subject
|
2
|
|
Overall Study
Unable to draw samples
|
1
|
Baseline Characteristics
Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025
Baseline characteristics by cohort
| Measure |
INVSENSOR00025
n=26 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive INVSENSOR00025 sensor.
INVSENSOR00025: Noninvasive pulse oximeter sensor
|
|---|---|
|
Age, Customized
<18 years old
|
0 Participants
n=5 Participants
|
|
Age, Customized
18 to 50 years old
|
26 Participants
n=5 Participants
|
|
Age, Customized
>50 years old
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
19 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Caucasian
|
6 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
8 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian or Pacific Islander
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black/Dark Skinned/African American
|
7 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Middle Eastern
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1-5 hours per subjectORi is an index value without a unit and ORi does not directly measure PaO2. Therefore, sensitivity, specificity, and concordance are calculated to evaluate changes in ORi relative to the changes in PaO2.
Outcome measures
| Measure |
INVSENSOR00025
n=26 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive INVSENSOR00025 sensor.
INVSENSOR00025: Noninvasive pulse oximeter sensor
|
|---|---|
|
Concordance for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 110 mmHg
|
99.68 percentage of accuracy
|
|
Concordance for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 150 mmHg
|
92.94 percentage of accuracy
|
|
Concordance for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 190 mmHg
|
91.48 percentage of accuracy
|
PRIMARY outcome
Timeframe: 1-5 Hours per subjectORi is an index value without a unit and ORi does not directly measure PaO2. Therefore, sensitivity, specificity, and concordance are calculated to evaluate changes in ORi relative to the changes in PaO2.
Outcome measures
| Measure |
INVSENSOR00025
n=26 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive INVSENSOR00025 sensor.
INVSENSOR00025: Noninvasive pulse oximeter sensor
|
|---|---|
|
Specificity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 110 mmHg
|
99.68 percentage of true negatives
|
|
Specificity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 150 mmHg
|
91.89 percentage of true negatives
|
|
Specificity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 190 mmHg
|
NA percentage of true negatives
Changes in ORi (DeltaORi) are being compared to changes in PaO2 (DeltaPaO2 )in the reference PaO2 range of 100-200 mmHg. For the PaO2 threshold of 190 mmHg, reference PaO2 samples are outside the level of detection and thus data is not available to compute specificity.
|
PRIMARY outcome
Timeframe: 1 to 5 hours per subjectORi is an index value without a unit and ORi does not directly measure PaO2. Therefore, sensitivity, specificity, and concordance are calculated to evaluate changes in ORi relative to the changes in PaO2.
Outcome measures
| Measure |
INVSENSOR00025
n=26 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive INVSENSOR00025 sensor.
INVSENSOR00025: Noninvasive pulse oximeter sensor
|
|---|---|
|
Sensitivity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 110 mmHg
|
NA percentage of true positives
Changes in ORi (DeltaORi) are being compared to changes in PaO2 (DeltaPaO2 )in the reference PaO2 range of 100-200 mmHg. For the PaO2 threshold of 110 mmHg, reference PaO2 samples are outside the level of detection and thus data is not available to compute sensitivity.
|
|
Sensitivity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 150 mmHg
|
93.67 percentage of true positives
|
|
Sensitivity for Changes in ORi Values as Compared to Corresponding Changes in PaO2 Values.
PaO2 Threshold: 190 mmHg
|
91.78 percentage of true positives
|
Adverse Events
INVSENSOR00025
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place